Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-02-25 @ 8:48 PM
Study NCT ID:
NCT01147393
Status:
TERMINATED
Last Update Posted:
2018-02-22
First Post:
2010-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
Sponsor:
Weill Medical College of Cornell University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Follicular Lymphoma | View |
Keywords: